|
|
|
A conversation with Panavance Therapeutics CEO Greg Bosch | Panavance CEO Greg Bosch discusses the company’s pursuit of a second trial for misetionamide, walking us through IND preparations, CRO selection, and securing funding. |
|
|
|
|
| From Powder To Particles With Jet Milling | Webinar | Lonza | Gain valuable insights into the jet milling process and Quality by Design approach for inhalation drug delivery and their potential applications in drug development. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|